The AMPs most studied with regard to HIV include α- and β-defensins, the cathelicidin LL-37, secretory leukocyte protease inhibitor (SLPI) and calprotectin; although others have been associated with either inhibiting HIV or promoting increased infection, as well as synthetic AMPs being proposed as anti-viral agents (Cole & Cole, 2017). This evidence concerns the gene ADSL and infection.